ARCHIVES

Triple-Negative Breast Cancer Equally Aggressive in Whites

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

April 15, 1977

Survivors With Gene Variant At More Risk For Heart Disease

June 25, 2010

In Brief: Simone, LoBuglio Lead AACI; AMA Honors B.J. Kennedy; FDA Meet Patient Advocates

July 31, 1992

Letter: Cancer Centers Need Ingenuity To Continue Clinical Research

October 27, 1995